Mast cells and basophils, which are activated by Igf and allergens through the high affinity IgE receptor (FctRI), play a prominent role in anaphylaxis in the mouse. Mice deficient in this receptor become resistant to passive anaphylaxis. As a first step
in developing an in vivo model that more closely mimics the IgE-mediated responses in man, we used a combination of
transgenic and embryonic stem cell technology to generate a mouse line in which the murine FceRl a-chain has been replaced
with its human homologue. We demonstrate here that these mice express a tetrameric high affinity IgE receptor, in which the
human a-chain associates with the murine p- and y-chains, and that upon triggering with relevant Ag, this receptor mediates
the initiation of the expected intracellular events. In addition, we show that the human a-chain restores an anaphylactic
response to the nonresponsive a-deficient parental mouse line. This “humanized” mouse represents a potentially important
model system, not only for studying the role of IgE in human immune responses, but also for testing potential therapeutic
reagents that can interfere with responses mediated through the human FceRI receptor.
Read full article here.